Related Experiment Videos
Plasma and urinary catecholamines as related to renal function in man
Kidney International
|January 1, 1987
Summary
Kidney function impairment does not significantly alter plasma or urinary norepinephrine and epinephrine levels, except in advanced renal failure where urinary excretion decreases. This finding is crucial for studies involving catecholamines in patients with kidney disease.
Area of Science:
- Nephrology
- Endocrinology
- Cardiovascular Physiology
Background:
- Progressive kidney disease and essential hypertension are associated with reduced renal plasma flow (ERPF) and glomerular filtration rate (GFR).
- The relationship between declining kidney function and catecholamine levels (norepinephrine and epinephrine) requires further investigation.
Purpose of the Study:
- To evaluate the association between ERPF and GFR and plasma or urinary norepinephrine (NE) and epinephrine (E) levels in patients with varying degrees of non-oliguric renal impairment.
- To determine if catecholamine levels are affected by chronic kidney disease or essential hypertension.
Main Methods:
- Simultaneous assessment of ERPF, GFR, plasma NE and E, and urinary NE and E excretion.
- Study population included normal subjects, patients with parenchymal kidney disease, and patients with essential hypertension.
Main Results:
- ERPF and GFR were significantly lower in patients with renal disease and essential hypertension compared to normal subjects.
- Plasma and urinary NE and E levels did not differ significantly among groups, showing no clear relationship with ERPF or GFR.
- A significant reduction in urinary NE and E excretion was observed only when GFR fell below 20 ml/min.
Conclusions:
- Chronic reduction in kidney excretory function does not substantially impact circulating norepinephrine and epinephrine levels.
- Urinary excretion of NE and E distinctly decreases in advanced renal failure (GFR < 20 ml/min).
- These findings are important for interpreting catecholamine studies in patients with impaired kidney function, considering potential alterations in urinary excretion at later stages.